Visual storytelling to secure partnerships and showcase innovation

Trusted by:

... and many others

Since 2023, we have been CHOP's trusted partner, providing visual content for scientific conferences to help CHOP raise awareness about its cutting-edge pediatric programs and clinical trials and attract investment.

So, we had to create an engaging and scientifically accurate animated video (3D MoA) explaining their therapies' mechanism of action against neurological diseases, lymphatic anomalies and others. The project involved the full-cycle development of high-quality animation, including scriptwriting, storyboard creation, and final rendering.

Target audience: hospitals, scientists, doctors.

CHOP website

Projects scope

CHOP is the nation's first hospital devoted exclusively to caring for children, established in 1855. Today, The Children's Hospital of Philadelphia is one of the leading pediatric hospitals and research facilities in the world.

3D medium animation

CHOP develops in-utero technology to modify babies' DNA during pregnancy and prevent possible diseases like muscular atrophy.

We focus on a gene-editing procedure. targeting genetic anomalies in fetus.

First, LNP is suspended in liquid in a syringe. Then, the syringe pierces mother’s abdomen and you see the pierced umbilical cord. FInally, LNP suspension is injected to fetal bloodstream.

This is the LNP (Liquid NanoPartice). LNPs varies from 60-150 nm (nanometers). The size depends on the components and the manufacturing methods. However, the typical LNP is around 80nm.

All payloads are incorporated inside the LNPs. We focus on mRNA and guide RNA (a short sequence of around 100 nucleotides or building blocks) as the payload.

The outside coating is Polyethylene glycol (PEG) with a molecular weight of 2000. The number of PEG molecules on the surface is around 3000.

Animation in detail

"This year marks the seventh year that the UAE EHS has invited CHOP to exhibit its pediatric innovation alongside EHS colleagues."

Arab Health 2025.

Our first project with CHOP for Arab Health 2023. The animation introduces CHOP's Microbubble Frontier Program, targeted gene delivery.

The animation demonstrates inert gas Xenon release through the blood-brain barrier to facilitate contrast imaging of brain ischemia.

First project

We also developed a standalone Web Progressive Application that is device-agnostic, can be launched and installed on clients' devices, works offline, and also functions like a regular website to demonstrate CHOP's research in vascular anomalies, including symptoms and treatment options.

It took us 6 weeks of the entire cycle to develop the app.

Application development

meetings

Communication with client is essential for us. To listen to them and provide with the best result

rounds

Two feedback rounds on the production stage

Claryfiying requirements

Scientific materials, proceeding

Storyboard development

Modeling & animation, voiceover recording

Shading, lighting, infographic creation, compositing

Rendering, video assembling, color correction, montage

Development of the preliminary video scenario, frames drawing

Providing the draft video

Providing final video, .mp4, FullHD, 1920x1080

weeks

Duration from the idea to the final delivery of the video (3 min 48 sec)

Timeline and Process

WEEK 1

WEEK 3

WEEK 6

WEEK 5

"feedback

Feedback

Robin Greving

Director Global Strategy and Business Development

3D MoA animation (brain virus delivery), 162 sec
3D MoA animation (lymphatic anomalies), 155 sec
3D MoA animation (in-utero gene-editing), 228 sec
still frames, 4K res
Web Application

Format: mov, mp4, ProRes video file. 1920x1080 pix 30 fps; 1280×1024

Results

Thank you for watching!

nanobotmedical.com

ABOUT NANOBOT

EU & US based,

operating global

300+

projects

4.9/5

customer satisfaction

NANOBOT IS

years of expertise in scientific communications

300+

completed projects

130+

MOA videos

700+

minutes of scientific video

An award-winning scientific storytelling company that values our clients’ time and money. We transform complex life science and medical product-related concepts into medically accurate, easy-to-understand, focused visual media.

Our mission:

to help bring 100 Impactful products/ideas to market by 2030 (6 years!).